Profiel
Lori Lawley is currently Chief Financial Officer & Secretary at Lumos Pharma, Inc. since 2020.
Former positions include Vice President-Finance & Controller at NewLink Genetics Corp.
from 2018 to 2020 and Senior Manager at Ernst & Young LLP from 2014 to 2015.
Education includes undergraduate and graduate degrees from McCombs School of Business.
Actieve functies van Lori Lawley
| Bedrijven | Functie | Begin |
|---|---|---|
| LUMOS PHARMA, INC. | Financieel Directeur/CFO | 04-07-2021 |
Eerdere bekende functies van Lori Lawley
| Bedrijven | Functie | Einde |
|---|---|---|
| LUMOS PHARMA, INC. | Comptroller/Controller/Auditor | 01-03-2020 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 01-04-2015 |
Opleiding van Lori Lawley
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
NewLink Genetics Corp.
NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
McCombs School of Business
McCombs School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lumos Pharma, Inc.
Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
















